Skip to main content
. 2021 Aug 10;12:713686. doi: 10.3389/fpsyt.2021.713686

Figure 6.

Figure 6

Scatter plot showing individual results for participants on and not on medication management with buprenorphine/suboxone following active vs. sham treatment with unilateral transcranial photobiomodulation. Note unexpected reduction in Hamilton Depression Rating Scale scores in two participants on buprenorphine who received sham treatment.